Table 1 Characteristics of the enrolled population
Patients analyzed at visit 1 | N = 20 |
|---|---|
Age (median, IQR) (years) | 42 (39–49) |
Gender (female) | 12 (60%) |
Race (Caucasian) | 19 (95%) |
Age at HAE diagnosis (median, IQR) (years) | 18.5 (13–32) |
HAE etiology (% type 1) | 20 (100%) |
Patients under prophylactic treatment (total) | 6 (30%) |
• Androgens | 5 (83.3%) |
• Antifibrinolytics | 1 (16.7%) |
• Pnf C1-INH | 0 (0%) |
Treatment used by patients for acute attacks before the study | |
• Pnf C1-INH | 18 (90%) |
• Icatibant | 12 (60%) |